European Journal of Molecular & Clinical Medicine

Abstract

A growing number of publications in the literature show that chronic pain is
also characteristic of patients with terminal renal failure (TRF). The disease tends to be
moderate or severe and affects virtually all aspects of health and quality of life.
Unfortunately, there is a lack of clinical and research focus in nephrology, and TAPN pain
is poorly understood. The article reflects the main aspects of the problem of pain
medication therapy for patients with terminal renal insufficiency receiving chronic
hemodialysis. The main pathophysiological mechanisms of medication influence on kidney
structures are described.